There are two cellular technologies for IoT battling for adoption around the world. How is uptake progressing? What decisions are being made? Are certain geographies more likely to choose one over the other? Find out at this webinar.
The webinar gives a bird’s eye view of CAT M1 and NB1 adoption, sharing observations about the global adoption status of the two technologies, and explaining who is launching what and where.
Key points:
By using Altair ALT1250LTE chipset rather than Bluetooth Low Energy (BLE) connectivity,
Wellvii can offer patients many benefits:
Wellvii specifically selected LTE to create an easy, hassle-free device for all patients —
including vulnerable patient populations who cannot reliably operate traditional Bluetooth-based medical devices.